ફેફસાનું કેન્સર (non-small cell)
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
ક્યાં જવું
આ ટ્રાયલ માટે ભારતમાં 6 હોસ્પિટલો દર્દીઓ લઈ રહી છે.
રજિસ્ટ્રી સમરી (ટેકનિકલ)
The purpose of this study is to understand if PF-08046054 alone works well compared to standard-of-care docetaxel alone in participants with non-small cell lung cancer (NSCLC) with PD-L1 expression greater than or equal to 1% and had cancer progression during or after treatment with PD-L1 or PD-1 inhibitors, platinum-based chemotherapy, and targeted treatment regimen(s) for participants with known actionable genomic alterations (AGAs). Participants in this study must have cancer that has spread through their body or can't be removed with surgery or treated with definitive radiation. Participa…
સ્પોન્સર: Pfizer
ClinicalTrials.gov પર NCT07144280
રજિસ્ટ્રીમાં છેલ્લે અપડેટ 13 Oct 2026 · અમે 20 Oct 2026 ના રોજ વાંચ્યું